Company page
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. is a public company traded under the ticker IKT in the American market. The company has a market capitalization of approximately $307.6 million. Inhibikase is focused on developing innovative therapies for neurodegenerative diseases.
- Ticker
- IKT:NASDAQ
- Asset type
- Stock
- Market cap
- $326.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD